Hancock Holding Co. acquired a new position in Medical Properties Trust Inc. (NYSE:MPW) during the second quarter, Holdings Channel reports. The fund acquired 14,535 shares of the real estate investment trust’s stock, valued at approximately $221,000.

Other large investors have also made changes to their positions in the company. MCF Advisors LLC boosted its stake in shares of Medical Properties Trust by 2.1% in the first quarter. MCF Advisors LLC now owns 8,261 shares of the real estate investment trust’s stock worth $107,000 after buying an additional 172 shares during the period. IFP Advisors Inc boosted its stake in shares of Medical Properties Trust by 28.5% in the first quarter. IFP Advisors Inc now owns 8,903 shares of the real estate investment trust’s stock worth $116,000 after buying an additional 1,977 shares during the period. Daiwa Securities Group Inc. boosted its stake in shares of Medical Properties Trust by 1.2% in the second quarter. Daiwa Securities Group Inc. now owns 8,500 shares of the real estate investment trust’s stock worth $129,000 after buying an additional 100 shares during the period. Creative Planning boosted its stake in shares of Medical Properties Trust by 5.9% in the second quarter. Creative Planning now owns 9,869 shares of the real estate investment trust’s stock worth $150,000 after buying an additional 550 shares during the period. Finally, BlackRock Japan Co. Ltd boosted its stake in shares of Medical Properties Trust by 0.5% in the first quarter. BlackRock Japan Co. Ltd now owns 12,577 shares of the real estate investment trust’s stock worth $163,000 after buying an additional 65 shares during the period. Institutional investors and hedge funds own 81.48% of the company’s stock.

Shares of Medical Properties Trust Inc. (NYSE:MPW) traded up 0.07% on Friday, reaching $14.89. 401,737 shares of the company were exchanged. The stock has a market capitalization of $3.55 billion, a price-to-earnings ratio of 18.20 and a beta of 1.02. Medical Properties Trust Inc. has a 52 week low of $9.61 and a 52 week high of $15.92. The firm’s 50 day moving average price is $15.02 and its 200 day moving average price is $14.35.

Medical Properties Trust (NYSE:MPW) last posted its earnings results on Thursday, August 4th. The real estate investment trust reported $0.32 EPS for the quarter, meeting analysts’ consensus estimates of $0.32. The business had revenue of $126.30 million for the quarter, compared to the consensus estimate of $128.04 million. Medical Properties Trust had a net margin of 38.03% and a return on equity of 9.06%. The company’s revenue for the quarter was up 26.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.30 EPS. Equities research analysts anticipate that Medical Properties Trust Inc. will post $1.30 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 13th. Shareholders of record on Thursday, September 15th will be given a dividend of $0.23 per share. This represents a $0.92 dividend on an annualized basis and a yield of 6.18%. The ex-dividend date is Tuesday, September 13th. Medical Properties Trust’s dividend payout ratio (DPR) is 115.00%.

Several research analysts have recently issued reports on MPW shares. TheStreet upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a research note on Tuesday, June 21st. Zacks Investment Research upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating and set a $17.00 target price on the stock in a research note on Tuesday, June 7th. Deutsche Bank AG started coverage on shares of Medical Properties Trust in a research note on Friday, July 22nd. They issued a “buy” rating and a $17.00 target price on the stock. Wells Fargo & Co. reiterated a “hold” rating on shares of Medical Properties Trust in a research note on Sunday, September 4th. Finally, JMP Securities downgraded shares of Medical Properties Trust from an “outperform” rating to a “market perform” rating in a research note on Friday, July 1st. Five research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $14.17.

In other Medical Properties Trust news, Chairman Edward K. Aldag, Jr. sold 50,000 shares of the firm’s stock in a transaction dated Tuesday, August 9th. The shares were sold at an average price of $15.52, for a total transaction of $776,000.00. Following the transaction, the chairman now owns 1,927,313 shares of the company’s stock, valued at approximately $29,911,897.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director G Steven Dawson sold 10,000 shares of the firm’s stock in a transaction dated Friday, August 19th. The shares were sold at an average price of $15.36, for a total transaction of $153,600.00. Following the transaction, the director now directly owns 67,729 shares in the company, valued at approximately $1,040,317.44. The disclosure for this sale can be found here. Company insiders own 1.44% of the company’s stock.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust (REIT) focused on investing in and owning net-leased healthcare facilities. It conducts all of its business through MPT Operating Partnership, L.P. It acquires and develops healthcare facilities and leases the facilities to healthcare operating companies under long-term net leases.

5 Day Chart for NYSE:MPW

Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust Inc. (NYSE:MPW).

Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.